Aytu Biopharma, Inc
AYTU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385818
No open-market purchases or sales by Aytu Biopharma, Inc insiders were filed in the last 90 days; 38 institutions reported holding it in 13F filings for Q2 2026, worth $10.6M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Aytu Biopharma, Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Aytu Biopharma, Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Disbrow Joshua R. | Chief Executive Officer | 237,203 | Jul 30, 2026 | 2 |
| Pyszczymuka Greg | Chief Commercial Officer | 56,102 | Jul 30, 2026 | 2 |
| Disbrow Jarrett | Chief Business Officer | 76,568 | Jul 30, 2026 | 2 |
| Selhorn Ryan J | Chief Financial Officer | 74,743 | Jul 30, 2026 | 2 |
| Liu Vivian H | Director | 29,825 | Jul 30, 2026 | 2 |
| Jain Abhinav | Director | 29,500 | Jul 30, 2026 | 2 |
| Dockery Carl | Director | 31,152 | Jul 30, 2026 | 2 |
| Donofrio John Jr. | Director | 23,762 | Jul 30, 2026 | 2 |
| Nantahala Capital Management, LLC | 10% Owner | – | Jun 9, 2025 | 0 |
| Mack Daniel | 10% Owner | – | Jun 9, 2025 | 0 |
| Harkey Wilmot B. | 10% Owner | – | Jun 9, 2025 | 0 |
| Oki Mark K | Chief Financial Officer | 190,000 | Aug 15, 2023 | 0 |
| Brooke Christopher | Chief Operating Officer | – | Aug 15, 2023 | 0 |
| Cantrell Gary | Director | 164,089 | Dec 23, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2025 (view filing) | Jun 9 | 1 day | Disbrow JarrettChief Business Officer | PPurchase | +16.7K | $1.50 | +$25.0K | +130.2%29.5K after | |
| Jun 10, 2025 (view filing) | Jun 9 | 1 day | Disbrow Joshua R.Chief Executive Officer | PPurchase | +66.7K | $1.50 | +$100.0K | +77.0%153.3K after | |
| Jun 9, 2025 (view filing)4:31 PM ET | Jun 6 | 3 days | Nantahala Capital Management, LLC and 2 others10% Owner | PPurchase | +4.00M | $1.50 | +$6.00M | –4.82M after | Derivative |
| Mar 3, 2025 (view filing) | Feb 28 | 3 days | Disbrow Joshua R.Chief Executive Officer | PPurchase | +15.0K | $1.30 | +$19.5K | +21.0%86.6K after | |
| Jun 20, 2023 (view filing) | Jun 16 | 4 days | Pyszczymuka GregChief Commerical Officer | PPurchase | +12.0K | $1.87 | +$22.4K | +120.8%21.9K after | |
| Jun 15, 2023 (view filing) | Jun 14 | 1 day | Disbrow Joshua R.Chief Executive Officer | PPurchase | +14.0K | $1.86 | +$26.0K | +24.3%71.6K after | |
| Dec 21, 2022 (view filing)9:17 AM ET | Dec 19 | 2 days | Disbrow Joshua R.Chief Executive Officer | PPurchase | +112.4K | $0.2229 | +$25.0K | +10.0%1.23M after | |
| Dec 21, 2022 (view filing)9:15 AM ET | Dec 19 | 2 days | Pyszczymuka GregChief Commercial Officer | PPurchase | +100.0K | $0.2448 | +$24.5K | +121.9%182.1K after | |
| Nov 28, 2022 (view filing)4:30 PM ET | Nov 18 | 10 days | Oki Mark KChief Financial Officer | PPurchase | +90.0K | $0.23 | +$20.7K | +90.0%190.0K after | Amended |
| Nov 28, 2022 (view filing)4:30 PM ET | Nov 18 | 10 days | Disbrow Joshua R.Chief Executive Officer | PPurchase | +222.0K | $0.237 | +$52.6K | +24.7%1.12M after | Amended |